sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
18-Apr-2015 15:27
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 976-991 out of 991.

<< < 35 | 36 | 37 | 38 | 39 | 40

Public Release: 6-May-2013
Proceedings of the National Academy of Sciences
Competing antibodies may have limited the protection achieved in HIV vaccine trial in Thailand
Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people.
Bill & Melinda Gates Foundation, NIH/National Institute of Allergy and Infectious Diseases, US Army Medical Research and Material Command

Contact: Sarah Avery
Duke University Medical Center

Public Release: 6-May-2013
New antiviral treatment could significantly reduce global burden of hepatitis C
Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) -- a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer. New prevention strategies are urgently required as people are continuing to be infected with HCV. Findings, published in Hepatology, reveal the impact of a new antiviral treatment that could potentially reduce HCV rates in some cities affected by chronic HCV prevalence by half over 15 years.

Contact: Caroline Clancy
University of Bristol

Public Release: 5-May-2013
GCP21 Strategic Meeting
Scientists alarmed by rapid spread of Brown Streak Disease in cassava
Cassava experts are reporting new outbreaks and the increased spread of Cassava Brown Streak Disease or CBSD, warning that the rapidly proliferating plant virus could cause a 50 percent drop in production of a crop that provides a significant source of food and income for 300 million Africans.

Contact: Michelle Geis
Burness Communications

Public Release: 4-May-2013
Pediatric Academic Societies Annual Meeting
Environmental Health Perspectives
Toxic waste sites cause healthy years of life lost
Toxic waste sites with elevated levels of lead and chromium cause a high number of "healthy years of life lost" in individuals living near 373 sites located in India, Philippines and Indonesia, according to a study by a Mount Sinai researcher published online today in Environmental Health Perspectives.
Blacksmith Institute

Contact: Renatt Brodsky
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 1-May-2013
New federal investment could save millions of lives
Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives. The lab-on-a-chip, designed by Ash Parameswaran and his students, is among 102 global research projects receiving $100,000 each through the federal government's Stars in Global Health program.
Grand Challenges Canada

Contact: Carol Thorbes
Simon Fraser University

Public Release: 1-May-2013
Rice U. professors share Lemelson-MIT award, donate prize money
Rice University bioengineering professors Rebecca Richards-Kortum and Maria Oden, the winners of the 2013 $100,000 Lemelson-MIT Award for Global Innovation, are dedicating their prize money toward the construction of a new neonatal nursery at the African hospital that has helped implement Rice's low-cost, student-designed health care technologies since 2007. The nursery will improve patient care at Queen Elizabeth Central Hospital in Blantyre, Malawi, and support technology innovation through Rice's Day One project.
Lemelson-MIT Program

Contact: Jade Boyd
Rice University

Public Release: 30-Apr-2013
Proceedings of the National Academy of Sciences
Economics influence fertility rates more than other factors
Based on a recent study by a University of Missouri anthropologist, economic changes have the greatest impact on reducing family size, and thus slowing population growth, compared to other factors. Understanding the causes of declining birth rates may lead to improved policies designed to influence fertility and result in reduced competition for food, water, land and wealth.
National Science Foundation

Contact: Tim Wall
University of Missouri-Columbia

Public Release: 29-Apr-2013
Warning system predicts outbreaks of dengue fever
With the help of a warning system which measures the risk of dengue incidence using precipitation and air temperature, it is possible to forecast the outbreak of dengue fever up to 16 weeks in advance. This is what Yien Ling Hii concludes in the dissertation she is defending at Umeå University in Sweden on 3 May.

Contact: Yien Ling Hii
Umea University

Public Release: 29-Apr-2013
Inventive: 102 bold new global health ideas win Grand Challenges Canada funding
59 innovators in 13 low and middle income countries and 43 in Canada will share $10.9 million in Canadian seed funding to pursue bold, creative ideas for tackling health problems in resource-poor parts of the world. The grants will advance 102 out-of-the-box innovations in remote diagnostics and monitoring, health protection, drug and vaccine development and accessibility, and other key health areas.

Contact: Terry Collins
Sandra Rotman Centre for Global Health

Public Release: 26-Apr-2013
International Liver Congress 2013
Developments in TACE and SIRT treatment in patients
Data from a number of clinical trials presented today at the International Liver Congress™ 2013 shed new light on the use of TACE and SIRT in the treatment of hepatocellular carcinoma.

Contact: Dimple Natali
European Association for the Study of the Liver

Public Release: 26-Apr-2013
New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.
Gilead Sciences

Contact: Joseph Carey
Texas Biomedical Research Institute

Public Release: 25-Apr-2013
A*STAR, Veredus create market's first lab-on-chip to detect multiple tropical infectious diseases
The Agency for Science, Technology and Research and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTropTM, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample.
Agency for Science, Technology and Research

Contact: Dr. Sarah Chang
Agency for Science, Technology and Research (A*STAR), Singapore

Public Release: 25-Apr-2013
International Liver Congress 2013
New studies prove lethal link between alcohol, weight
Research announced today at the International Liver CongressTM 2013 has revealed the deadly impact that alcohol and body weight have on liver disease.

Contact: Dimple Natali
European Association for the Study of the Liver

Public Release: 24-Apr-2013
International Liver Congress 2013
Direct-acting antivirals now ready for prime time
New data from a number of clinical trials presented for the first time at the International Liver Congress™ 2013 demonstrate encouraging results in the use of new direct-acting antiviral agents for the treatment of hepatitis C.

Contact: Dimple Natali
European Association for the Study of the Liver

Public Release: 24-Apr-2013
International Liver Congress 2013
NASH diagnosis set to improve with non-invasive tool
A Chinese study presented at the International Liver CongressTM 2013 has demonstrated the accuracy of a non-invasive test for non-alcoholic steatohepatitis diagnosis.

Contact: Dimple Natali
European Association for the Study of the Liver

Public Release: 23-Apr-2013
AfriCoLeish receives funding boost from European Union
Research and development project, AfriCoLeish, is supported by the European Union Seventh Framework Programme through a grant of €3 million. The project will run for three years and aims to test new treatments for kala-azar (visceral leishmaniasis, or VL) and co-infection of the disease with HIV in Ethiopia and Sudan.
European Union

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Showing releases 976-991 out of 991.

<< < 35 | 36 | 37 | 38 | 39 | 40